This will take effect July 16, 2012
Overview and Clinical Utility:
Effective July 16, 2012, Rubella IgM antibody testing will be performed in house on the Bioplex 2200 using a multiplex flow immunoassay methodology. Rubella IgM (German measles) is a viral infection with worldwide distribution. Testing immediately post-exposure is of no value without a later convalescent specimen. While the presence of IgM antibodies suggests current or recent infection, low levels of IgM antibodies may occasionally persist for more than 12 months post-infection or immunization.
Click Here to read more.